Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 5 sources · 5 days · First seen 8 days ago · Last updated 3 days ago

Biotechnology sector market volatility

Overview

The biotechnology sector experienced notable stock price volatility and varied financial reporting in late August 2026.

Initially, Recursion Pharmaceuticals and CRISPR Therapeutics saw significant share price gains, with Recursion rising 9.8% and CRISPR Therapeutics increasing by 11.2%. Analyst outlooks for these firms remained mixed, ranging from buy ratings to sell ratings.

By late August, market activity expanded across several biotech firms. Xencor, Inc. reached a new 52-week high following quarterly revenue that exceeded analyst expectations. In contrast, REGENXBIO Inc. and Nanobiotix S.A. both experienced downward gaps in their share prices. Additionally, Omeros Corporation reported quarterly revenue that beat consensus estimates, even as its Chief Accounting Officer sold a portion of his shares.

Entities

Citigroup · Nanobiotix S.A. · Recursion Pharmaceuticals · Costco Wholesale · Omeros Corporation

Timeline

3 days ago

[BUSINESS] 3 sources
Market Update: Costco, Xencor, and various biotech firms report earnings and stock shifts
Multiple companies reported diverse market movements, including Costco's strong quarterly performance, Xencor reaching a 52-week high, and share price drops for REGENXBIO and Nanobiotix.
8 days ago

[BUSINESS] 3 sources
Biotech stocks Recursion Pharmaceuticals and CRISPR Therapeutics see price gains
Biotechnology stocks Recursion Pharmaceuticals and CRISPR Therapeutics saw significant share price increases on Wednesday amid varied analyst ratings and price target adjustments.

Sources

ad-hoc-news.de · mommygearest.com · otravel.com · stocknews.com · theascent.com